Related Experiment Video
Updated: Sep 24, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Power analysis for cluster randomized trials with continuous coprimary endpoints
Siyun Yang1, Mirjam Moerbeek2, Monica Taljaard3,4
1Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
New methods enable accurate sample size and power calculations for cluster randomized trials (CRTs) with multiple continuous endpoints. This addresses a gap in pragmatic trial design, improving the reliability of health care intervention evaluations.
Area of Science:
- Biostatistics
- Clinical Trials
- Health Services Research
Background:
- Pragmatic trials frequently use cluster randomization (CRTs) for logistical or scientific reasons.
- Coprimary endpoints are common in CRTs but often overlooked in sample size and power calculations.
- Existing power analysis methods for CRTs primarily address binary endpoints, leaving a gap for continuous outcomes.
Purpose of the Study:
- To develop methods for sample size and power calculations for CRTs with multiple continuous coprimary endpoints.
- To provide a statistical framework for handling complex correlation structures within clusters.
- To extend existing methods to accommodate unequal cluster sizes.
Main Methods:
- Derivation of the closed-form joint distribution for K treatment effect estimators using a multivariate linear mixed model (MLMM).
- Characterization of the relationship between statistical power and various intraclass correlation coefficients.
- Approximation of the joint distribution under unequal cluster sizes using cluster size mean and coefficient of variation.
Main Results:
- The proposed method accurately predicts statistical power for CRTs with continuous coprimary endpoints.
- The derived methods account for multiple intraclass correlation types within the MLMM framework.
- Simulations demonstrate good agreement between predicted and empirical power, even with estimated MLMM parameters.
Conclusions:
- The developed methods provide a robust approach for sample size and power determination in CRTs with continuous coprimary endpoints.
- This work addresses a critical need in pragmatic trial design, enhancing the statistical rigor of health care intervention studies.
- The approach is applicable to real-world CRTs and facilitates more reliable evaluation of interventions.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
The Mantel-Cox Log-Rank Test
Cancer Survival Analysis
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...

